Topic: Food and Drug Administration

14May/18

FDA Grants Priority Review of Genentech’s Tecentriq

Genentech, a member of the Roche Group today announced that the FDA has accepted the company’s supplemental Biologics License Application (sBLA) and granted Priority Review for Tecentriq (atezolizumab), in combination with Avastin (bevacizumab), paclitaxelRead More…

12Mar/18

Grifols pushes for genetic COPD testing in Rare Disease Day campaign

In rare cases, the lung disease COPD can be genetic. So Wednesday, on Rare Disease Day, Grifols is launching an awareness campaign to encourage COPD patients to get tested. Of the estimated 11 millionRead More…

Proposed changes to nutrition labels and marketing food to children

The nutrition labels on packaged food and beverages may be due a makeover, thanks to proposals from the Food and Drug Administration. The agency is accepting public comment on the proposed changes for 90 days. If passed, the proposed changes will mark the first major overhaul for nutrition labels since the Food and Drug Administration (FDA) made them compulsory 20 years ago. (more…)